In the current study, AR-515 phosphorylation is associated with decreased Ki67 in ER+ve tumours, confirming previous reports that AR is a good prognostic factor in ER+ve breast cancer due to an anti-proliferative effect [27, 28]. Here, MKI67 is linked to breast cancer.